TOT BIOPHARM possesses advanced ADC conjugation and analysis technologies, and has established a rigorous quality management system and GMP-compliant commercial production base. With its validated R&D and industrialization platform for mAbs and ADCs, the company provides trusted one-stop CDMO services and serves as the best strategic partner in the field of ADC drug development.
One-site manufacturing, efficient resource utilization
Commercial ADC manufacturing plants integrating the antibody, ADC DS and DP to be completed at one site, achieving faster project timeline, lower cost and lower risks
High-quality development, complete capabilities
Complete ADC analysis technology platform and independent analysis capabilities of critical quality attributes, ensuring high-quality product development
Professional and experienced full-process service team
A complete professional team provides services from R&D, process development, clinical batch manufacturing, IND, BLA/NDA applications to commercial manufacturing, to ensure the smooth development of the project
